TABLE OF CONTENTS 1. INTRODUCTION 32 1.1. OBJECTIVES OF THE STUDY 32 1.2. MARKET DEFINITION 32 1.3. OVERVIEW OF ASIA PACIFIC TOPICAL CORTICOSTEROIDS MARKET 32 1.4. CURRENCY AND PRICING 33 1.5. LIMITATION 33 1.6. MARKETS COVERED 34 2. MARKET SEGMENTATION 38 2.1. MARKETS COVERED 38 2.2. GEOGRAPHIC SCOPE 40 2.3. YEARS CONSIDERED FOR THE STUDY 41 2.4. CURRENCY AND PRICING 41 2.5. RESEARCH METHODOLOGY 42 2.6. PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 46 2.7. SECONDARY SOURCES 47 2.8. ASSUMPTIONS 47 3. MARKET OVERVIEW 48 3.1. DRIVERS 49 3.1.1. INCREASING PREVALENCE OF CHRONIC DISEASE OR CONDITION 49 3.1.2. GROWING NUMBER OF GERIATRIC POPULATION 49 3.1.3. GROWTH IN DEMAND OF TOPICAL DRUG DELIVERY DRUGS 49 3.1.4. INCREASING INVESTMENT IN RESEARCH AND DEVELOPMENT 50 3.1.5. NEW PRODUCT LAUNCHESBY KEY PLAYERS 50   3.2. RESTRAINTS 50 3.2.1. EXPIRY OF PATENT FOR DRUGS 50 3.2.2. WEAK REIMBURSEMENT POLICIES 50 3.2.3. STRINGENT REGULATORY POLICIES 51 3.3. OPPORTUNITIES 51 3.3.1. HIGH INVESTMENTS IN R&D TO INNOVATE NEW PRODUCTS 51 3.3.2. LUCRATIVE OPPORTUNITIES IN EMERGING MARKET 51 3.3.3. INCREASING MERGERS AND ACQUISITIONS 51 3.4. CHALLENGES 52 3.4.1. PRICING PRESSURE BY GOVERNMENT 52 3.4.2. SIDE EFFECTSOF TOPICAL CORTICOSTEROIDS 53 4. EXECUTIVE SUMMARY 54 5. PREMIUM INSIGHTS 56 6. ASIA PACIFIC TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME 59 6.1. OVERVIEW 60 6.2. FLUDROXYCORTIDE 62 6.3. TRIAMCINOLONE ACETONIDE 63 6.4. FLUOCINOLONE ACETONIDE 64 6.5. ANTISEPTICS 65 6.6. BETAMETHASONE 66 6.7. CLOBETASONE PROPIONATE 67 6.8. CLOBETASONE BUTYRATE 68 6.9. HALOBETASONE 69 6.10. MOMETASONE 70 6.11. OTHERS 71   7. ASIA PACIFIC TOPICAL CORTICOSTEROIDS MARKET, BY POTENCY CLASS 72 7.1. OVERVIEW 73 7.2. ULTRA HIGH 75 7.2.1. CLOBETASOL PROPIONATE 76 7.2.2. DIFLORASONE DIACETATE 76 7.2.3. BETAMETHASONE DIPROPIONATE GLYCOL 76 7.3. HIGH 77 7.3.1. AMCINONIDE 78 7.3.2. BETAMETHASONE DIPROPIONATE 78 7.3.3. DESOXIMETASONE 78 7.3.4. FLUOCINONIDE 78 7.3.5. OTHERS 79 7.4. MODERATE 79 7.4.1. DESOXIMETASONE 80 7.4.2. FLUOCINOLONE ACETONIDE 80 7.4.3. FLUDROXYCORTIDE 81 7.4.4. HYDROCORTISONE VALERATE 81 7.4.5. TRIAMCINOLONE ACETONIDE 81 7.4.6. CLOBETASONE BUTYRATE 81 7.4.7. OTHERS 81 7.5. MILD 82 7.5.1. HYDROCORTISONE 83 7.5.2. HYDROCORTISONE ACETATE 83 7.5.3. BETAMETHASONE VALERATE 83 7.5.4. DESONIDE 84 7.5.5. FLUOCINOLONE ACETONIDE 84 7.5.6. OTHERS 84   8. ASIA PACIFIC TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION 85 8.1. OVERVIEW 86 8.2. ACNE 88 8.3. DERMATITIS 89 8.4. PSORIASIS 89 8.5. SKIN INFECTION 91 8.6. HYPERPIGMENTATION 92 8.7. MELASMA 93 8.8. OTHERS 94 9. ASIA PACIFIC TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE 95 9.1. OVERVIEW 96 9.2. OINTMENTS 98 9.3. CREAMS 99 9.4. LIQUID & SOLUTIONS 100 9.5. LOTIONS 101 9.6. GEL 102 9.7. OILS 103 9.8. PASTES 104 9.9. SPRAYS 105 9.10. OTHERS 106 10. ASIA PACIFIC TOPICAL CORTICOSTEROIDS MARKET, BY END-USER 107 10.1. OVERVIEW 108 10.2. HOSPITAL 110 10.3. DERMATOLOGY CLINICS 111 10.4. HOMECARE 112 10.5. OTHERS 113   11. ASIA PACIFIC TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL 114 11.1. OVERVIEW 115 11.2. HOSPITAL PHARMACIES 117 11.3. PHARMACY STORES 118 11.4. ONLINE PHARMACIES 119 11.5. OTHERS 120 12. ASIA PACIFIC TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE 121 12.1. OVERVIEW 122 12.2. OVER THE COUNTER (OTC) BASED 124 12.3. PRESCRIPTION BASED 125 13. ASIA PACIFIC TOPICAL CORTICOSTEROIDS MARKET, BY BRANDS 126 13.1. OVERVIEW 127 13.2. BETNOVATE 127 13.3. BETNOVATE N 127 13.4. PANDERM PLUS 128 13.5. LOBATE 128 13.6. COSVATE G 128 13.7. CLOP G 128 13.8. TENOVATE GN 128 13.9. LOBATE GM 128 13.10. ULTIDERM 128 13.11. FLUTIVATE 129 13.12. FEXIN 129 13.13. MOMATE 129 13.14. CANDIDERM 129 13.15. OTHERS 129   14. ASIA PACIFIC TOPICAL CORTICOSTEROIDS MARKET, BY GEOGRAPHY 130 14.1. OVERVIEW 131 14.2. ASIA-PACIFIC 230 14.2.1. JAPAN 242 14.2.2. CHINA 247 14.2.3. INDIA 253 14.2.4. SOUTH KOREA 259 14.2.5. AUSTRALIA 264 14.2.6. SINGAPORE 269 14.2.7. THAILAND 274 14.2.8. MALAYSIA 279 14.2.9. INDONESIA 284 14.2.10. PHILIPPINES 289 14.2.11. REST OF ASIA PACIFIC 294 15. ASIA PACIFIC TOPICAL CORTICOSTEROIDS MARKET, COMPANY LANDSCAPE 331 15.1. COMPANY SHARE ANALYSIS: ASIA PACIFIC 331 16. COMPANY PROFILES 335 16.1. GLAXOSMITHKLINE PLC. 335 16.1.1. COMPANY OVERVIEW 335 16.1.2. GLAXOSMITHKLINE PLC: REVENUE ANALYSIS 335 16.1.3. PRODUCT PORTFOLIO 336 16.1.4. RECENT DEVELOPMENTS 336 16.2. MERCK & CO. INC. 337 16.2.1. COMPANY OVERVIEW 337 16.2.2. MERCK & CO. INC.: REVENUE ANALYSIS 337 16.2.3. PRODUCT PORTFOLIO 338 16.2.4. RECENT DEVELOPMENTS 338   16.3. LEO PHARMA 339 16.3.1. COMPANY OVERVIEW 339 16.3.2. LEO PHARMA: REVENUE ANALYSIS 339 16.3.3. PRODUCT PORTFOLIO 340 16.3.4. RECENT DEVELOPMENTS 340 16.4. ALMIRALL S.A. 341 16.4.1. COMPANY OVERVIEW 341 16.4.2. ALMIRALL S.A.: COMPANY SNAPSHOT 341 16.4.3. PRODUCT PORTFOLIO 342 16.4.4. RECENT DEVELOPMENTS 342 16.5. VALEANT PHARMACEUTICALS INTERNATIONAL 343 16.5.1. COMPANY OVERVIEW 343 16.5.2. VALEANT PHARMACEUTICALS INTERNATIONAL: REVENUE ANALYSIS 343 16.5.3. PRODUCT PORTFOLIO 344 16.5.4. RECENT DEVELOPMENTS 344 16.6. ZYLERA PHARMACEUTICALS 345 16.6.1. COMPANY OVERVIEW 345 16.6.2. ZYLERA PHARMACEUTICALS: COMPANY SNAPSHOT 345 16.6.3. PRODUCT PORTFOLIO 346 16.6.4. RECENT DEVELOPMENTS 346 16.7. SANDOZ INTERNATIONAL GMBH 347 16.7.1. COMPANY OVERVIEW 347 16.7.2. SANDOZ INTERNATIONAL GMBH: REVENUE ANALYSIS 347 16.7.3. PRODUCT PORTFOLIO 348 16.7.4. RECENT DEVELOPMENTS 348 16.8. PFIZER INC. 349 16.8.1. COMPANY OVERVIEW 349 16.8.2. PFIZER INC.: REVENUE ANALYSIS 349 16.8.3. PRODUCT PORTFOLIO 350 16.8.4. RECENT DEVELOPMENTS 350 16.9. SANOFI S.A. 351 16.9.1. COMPANY OVERVIEW 351 16.9.2. SANOFI S.A.: COMPANY REVENUE ANALYSIS 351 16.9.3. PRODUCT PORTFOLIO 352 16.9.4. RECENT DEVELOPMENTS 352 16.10. ASTRAZENECA 353 16.10.1. COMPANY OVERVIEW 353 16.10.2. ASTRAZENECA: REVENUE ANALYSIS 353 16.10.3. PRODUCT PORTFOLIO 354 16.10.4. RECENT DEVELOPMENTS 354 17. RELATED REPORTS 355

TABLE LIST TABLE 1 PRICE OF VARIOUS PRODUCTS CONTAINING TOPICAL CORTICOSTEROIDS AND ANTIMICROBIALS 52 TABLE 2 ASIA PACIFIC TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015– 2024 (USD MILLION) 61 TABLE 3 ASIA PACIFIC FLUDROXYCORTIDE MARKET, BY REGION, 2015– 2024 (USD MILLION) 62 TABLE 4 ASIA PACIFIC TRIAMCINOLONE ACETONIDE MARKET, BY REGION, 2015– 2024 (USD MILLION) 63 TABLE 5 ASIA PACIFIC FLUOCINOLONE ACETONIDE MARKET, BY REGION, 2015– 2024 (USD MILLION) 64 TABLE 6 ASIA PACIFIC ANTISEPTICS MARKET, BY REGION, 2015– 2024 (USD MILLION) 65 TABLE 7 ASIA PACIFIC BETAMETHASONE MARKET, BY REGION, 2015– 2024 (USD MILLION) 66 TABLE 8 ASIA PACIFIC CLOBETASONE PROPIONATE MARKET, BY REGION, 2015– 2024 (USD MILLION) 67 TABLE 9 ASIA PACIFIC CLOBETASONE BUTYRATE MARKET, BY REGION, 2015– 2024 (USD MILLION) 68 TABLE 10 ASIA PACIFIC HALOBETASONE MARKET, BY REGION, 2015– 2024 (USD MILLION) 69 TABLE 11 ASIA PACIFIC MOMETASONE MARKET, BY REGION, 2015– 2024 (USD MILLION) 70 TABLE 12 ASIA PACIFIC OTHERS MARKET, BY REGION, 2015– 2024 (USD MILLION) 71 TABLE 13 ASIA PACIFIC TOPICAL CORTICOSTEROIDS MARKET, BY POTENCY CLASS, 2015– 2024 (USD MILLION) 74 TABLE 14 ASIA PACIFIC ULTRA HIGH POTENCY TOPICAL CORTICOSTEROIDS MARKET, BY REGION, 2015-2024 (USD MILLION) 75 TABLE 15 ASIA PACIFIC ULTRA HIGH POTENCY CLASS MARKET, BY TYPE, 2015– 2024 (USD MILLION) 76 TABLE 16 ASIA PACIFIC HIGH POTENCY TOPICAL CORTICOSTEROIDS MARKET, BY REGION, 2015 – 2024 (USD MILLION) 77 TABLE 17 ASIA PACIFIC HIGH POTENCY CLASS MARKET, BY TYPE, 2015– 2024 (USD MILLION) 78 TABLE 18 ASIA PACIFIC MODERATE TOPICAL CORTICOSTEROIDS MARKET, BY REGION, 2015 – 2024 (USD MILLION) 79 TABLE 19 ASIA PACIFIC MODERATE HIGH POTENCY CLASS MARKET, BY TYPE, 2015– 2024 (USD MILLION) 80 TABLE 20 ASIA PACIFIC MILD TOPICAL CORTICOSTEROIDS MARKET, BY REGION, 2015 – 2024 (USD MILLION) 82 TABLE 21 ASIA PACIFIC MILD POTENCY CLASS MARKET, BY TYPE, 2015– 2024 (USD MILLION) 83 TABLE 22 ASIA PACIFIC TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION) 87 TABLE 23 ASIA PACIFIC ACNE TOPICAL CORTICOSTEROIDS MARKET, BY REGION, 2015 – 2024 (USD MILLION) 88 TABLE 24 ASIA PACIFIC DERMATITIS TOPICAL CORTICOSTEROIDS MARKET, BY REGION, 2015 – 2024 (USD MILLION) 89 TABLE 25 ASIA PACIFIC PSORIASIS TOPICAL CORTICOSTEROIDS MARKET, BY REGION, 2015 – 2024 (USD MILLION) 90 TABLE 26 ASIA PACIFIC SKIN INFECTION TOPICAL CORTICOSTEROIDS MARKET, BY REGION, 2015 – 2024 (USD MILLION) 91 TABLE 27 ASIA PACIFIC HYPERPIGMENTATION TOPICAL CORTICOSTEROIDS MARKET, BY REGION, 2015 – 2024 (USD MILLION) 92 TABLE 28 ASIA PACIFIC MELASMA TOPICAL CORTICOSTEROIDS MARKET, BY REGION, 2015 – 2024 (USD MILLION) 93 TABLE 29 ASIA PACIFIC OTHERS TOPICAL CORTICOSTEROIDS APPLICATION MARKET, BY REGION, 2015 – 2024 (USD BILLION) 94 TABLE 30 ASIA PACIFIC TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE, 2015– 2024 (USD MILLION) 97 TABLE 31 ASIA PACIFIC OINTMENT TOPICAL CORTICOSTEROIDS MARKET, BY REGION, 2015-2024 (USD MILLION) 98 TABLE 32 ASIA PACIFIC CREAMS TOPICAL CORTICOSTEROIDS MARKET, BY REGION, 2015 – 2024 (USD MILLION) 99 TABLE 33 ASIA PACIFIC LIQUID & SOLUTIONS TOPICAL CORTICOSTEROIDS MARKET, BY REGION, 2015 – 2024 (USD MILLION) 100 TABLE 34 ASIA PACIFIC LOTIONS TOPICAL CORTICOSTEROIDS MARKET, BY REGION, 2015 – 2024 (USD MILLION) 101 TABLE 35 ASIA PACIFIC GEL TOPICAL CORTICOSTEROIDS MARKET, BY REGION, 2015 – 2024 (USD MILLION) 102 TABLE 36 ASIA PACIFIC OILS TOPICAL CORTICOSTEROIDS MARKET, BY REGION, 2015 – 2024 (USD MILLION) 103 TABLE 37 ASIA PACIFIC PASTES TOPICAL CORTICOSTEROIDS MARKET, BY REGION, 2015 – 2024 (USD MILLION) 104 TABLE 38 ASIA PACIFIC SPRAYS TOPICAL CORTICOSTEROIDS MARKET, BY REGION, 2015 – 2024 (USD MILLION) 105 TABLE 39 ASIA PACIFIC OTHERS TOPICAL CORTICOSTEROIDS MARKET, BY REGION, 2015 – 2024 (USD MILLION) 106 TABLE 40 ASIA PACIFIC TOPICAL CORTICOSTEROIDS MARKET, BY END-USER, 2015– 2024 (USD MILLION) 109 TABLE 41 ASIA PACIFIC HOSPITAL TOPICAL CORTICOSTEROIDS MARKET, BY REGION, 2015 – 2024 (USD MILLION) 110 TABLE 42 ASIA PACIFIC DERMATOLOGY CLINICS TOPICAL CORTICOSTEROIDS MARKET, BY REGION, 2015 – 2024 (USD MILLION) 111 TABLE 43 ASIA PACIFIC HOMECARE TOPICAL CORTICOSTEROIDS MARKET, BY REGION, 2015 – 2024 (USD MILLION) 112 TABLE 44 ASIA PACIFIC OTHERS TOPICAL CORTICOSTEROIDS MARKET, BY REGION, 2015 – 2024 (USD MILLION) 113 TABLE 45 ASIA PACIFIC TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015– 2024 (USD MILLION) 116 TABLE 46 ASIA PACIFIC HOSPITAL PHARMACIES TOPICAL CORTICOSTEROIDS MARKET, BY REGION, 2015 – 2024 (USD MILLION) 117 TABLE 47 ASIA PACIFIC PHARMACY STORES TOPICAL CORTICOSTEROIDS MARKET, BY REGION, 2015 – 2024 (USD MILLION) 118 TABLE 48 ASIA PACIFIC ONLINE PHARMACIES TOPICAL CORTICOSTEROIDS MARKET, BY REGION, 2015 – 2024 (USD MILLION) 119 TABLE 49 ASIA PACIFIC OTHERS TOPICAL CORTICOSTEROIDS MARKET, BY REGION, 2015 – 2024 (USD MILLION) 120 TABLE 50 ASIA PACIFIC TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE, 2015– 2024 (USD MILLION) 123 TABLE 51 ASIA PACIFIC OVER THE COUNTER (OTC) BASED TOPICAL CORTICOSTEROIDS MARKET, BY REGION, 2015-2024 (USD MILLION) 124 TABLE 52 ASIA PACIFIC PRESCRIPTION BASED TOPICAL CORTICOSTEROIDS MARKET, BY REGION, 2015 – 2024 (USD MILLION) 125 TABLE 53 ASIA PACIFIC TOPICAL CORTICOSTEROIDS MARKET, BY COUNTRY, 2015 – 2024 (USD MILLION) 137 TABLE 54 ASIA-PACIFIC TOPICAL CORTICOSTEROIDS MARKET, BY COUNTRY, 2015 – 2024 (USD MILLION) 236 TABLE 55 ASIA-PACIFIC TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015 – 2024 (USD MILLION) 237 TABLE 56 ASIA-PACIFIC TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE , 2015 – 2024 (USD MILLION) 238 TABLE 57 ASIA-PACIFIC TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION) 238 TABLE 58 ASIA-PACIFIC TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE, 2015 – 2024 (USD MILLION) 239 TABLE 59 ASIA-PACIFIC TOPICAL CORTICOSTEROIDS MARKET, BY POTENCY CLASS, 2015 – 2024 (USD MILLION) 240 TABLE 60 ASIA-PACIFIC TOPICAL CORTICOSTEROIDS MARKET, BY END-USER, 2015 – 2024 (USD MILLION) 240 TABLE 61 ASIA-PACIFIC TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) 241 TABLE 62 JAPAN TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015 – 2024 (USD MILLION) 242 TABLE 63 JAPAN TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE , 2015 – 2024 (USD MILLION) 243 TABLE 64 JAPAN TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION) 243 TABLE 65 JAPAN TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE, 2015 – 2024 (USD MILLION) 244 TABLE 66 JAPAN TOPICAL CORTICOSTEROIDS MARKET, BY POTENCY CLASS, 2015 – 2024 (USD MILLION) 245 TABLE 67 JAPAN TOPICAL CORTICOSTEROIDS MARKET, BY END-USER, 2015 – 2024 (USD MILLION) 245 TABLE 68 JAPAN TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) 246 TABLE 69 CHINA TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015 – 2024 (USD MILLION) 247 TABLE 70 CHINA TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE , 2015 – 2024 (USD MILLION) 248 TABLE 71 CHINA TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION) 248 TABLE 72 CHINA TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE, 2015 – 2024 (USD MILLION) 249 TABLE 73 CHINA TOPICAL CORTICOSTEROIDS MARKET, BY POTENCY CLASS, 2015 – 2024 (USD MILLION) 250 TABLE 74 CHINA TOPICAL CORTICOSTEROIDS MARKET, BY END-USER, 2015 – 2024 (USD MILLION) 251 TABLE 75 CHINA TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) 252 TABLE 76 INDIA TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015 – 2024 (USD MILLION) 253 TABLE 77 INDIA TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE , 2015 – 2024 (USD MILLION) 254 TABLE 78 INDIA TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION) 254 TABLE 79 INDIA TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE, 2015 – 2024 (USD MILLION) 255 TABLE 80 INDIA TOPICAL CORTICOSTEROIDS MARKET, BY POTENCY CLASS, 2015 – 2024 (USD MILLION) 256 TABLE 81 INDIA TOPICAL CORTICOSTEROIDS MARKET, BY END-USER, 2015 – 2024 (USD MILLION) 257 TABLE 82 INDIA TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) 258 TABLE 83 SOUTH KOREA TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015 – 2024 (USD MILLION) 259 TABLE 84 SOUTH KOREA TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE , 2015 – 2024 (USD MILLION) 260 TABLE 85 SOUTH KOREA TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION) 260 TABLE 86 SOUTH KOREA TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE, 2015 – 2024 (USD MILLION) 261 TABLE 87 SOUTH KOREA TOPICAL CORTICOSTEROIDS MARKET, BY POTENCY CLASS, 2015 – 2024 (USD MILLION) 262 TABLE 88 SOUTH KOREA TOPICAL CORTICOSTEROIDS MARKET, BY END-USER, 2015 – 2024 (USD MILLION) 262 TABLE 89 SOUTH KOREA TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) 263 TABLE 90 AUSTRALIA TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015 – 2024 (USD MILLION) 264 TABLE 91 AUSTRALIA TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE , 2015 – 2024 (USD MILLION) 265 TABLE 92 AUSTRALIA TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION) 265 TABLE 93 AUSTRALIA TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE, 2015 – 2024 (USD MILLION) 266 TABLE 94 AUSTRALIA TOPICAL CORTICOSTEROIDS MARKET, BY POTENCY CLASS, 2015 – 2024 (USD MILLION) 267 TABLE 95 AUSTRALIA TOPICAL CORTICOSTEROIDS MARKET, BY END-USER, 2015 – 2024 (USD MILLION) 267 TABLE 96 AUSTRALIA TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) 268 TABLE 97 SINGAPORE TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015 – 2024 (USD MILLION) 269 TABLE 98 SINGAPORE TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE , 2015 – 2024 (USD MILLION) 270 TABLE 99 SINGAPORE TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION) 270 TABLE 100 SINGAPORE TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE, 2015 – 2024 (USD MILLION) 271 TABLE 101 SINGAPORE TOPICAL CORTICOSTEROIDS MARKET, BY POTENCY CLASS, 2015 – 2024 (USD MILLION) 272 TABLE 102 SINGAPORE TOPICAL CORTICOSTEROIDS MARKET, BY END-USER, 2015 – 2024 (USD MILLION) 272 TABLE 103 SINGAPORE TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) 273 TABLE 104 THAILAND TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015 – 2024 (USD MILLION) 274 TABLE 105 THAILAND TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE , 2015 – 2024 (USD MILLION) 275 TABLE 106 THAILAND TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION) 275 TABLE 107 THAILAND TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE, 2015 – 2024 (USD MILLION) 276 TABLE 108 THAILAND TOPICAL CORTICOSTEROIDS MARKET, BY POTENCY CLASS, 2015 – 2024 (USD MILLION) 277 TABLE 109 THAILAND TOPICAL CORTICOSTEROIDS MARKET, BY END-USER, 2015 – 2024 (USD MILLION) 277 TABLE 110 THAILAND TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) 278 TABLE 111 MALAYSIA TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015 – 2024 (USD MILLION) 279 TABLE 112 MALAYSIA TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE , 2015 – 2024 (USD MILLION) 280 TABLE 113 MALAYSIA TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION) 280 TABLE 114 MALAYSIA TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE, 2015 – 2024 (USD MILLION) 281 TABLE 115 MALAYSIA TOPICAL CORTICOSTEROIDS MARKET, BY POTENCY CLASS, 2015 – 2024 (USD MILLION) 282 TABLE 116 MALAYSIA TOPICAL CORTICOSTEROIDS MARKET, BY END-USER, 2015 – 2024 (USD MILLION) 282 TABLE 117 MALAYSIA TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) 283 TABLE 118 INDONESIA TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015 – 2024 (USD MILLION) 284 TABLE 119 INDONESIA TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE , 2015 – 2024 (USD MILLION) 285 TABLE 120 INDONESIA TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION) 285 TABLE 121 INDONESIA TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE, 2015 – 2024 (USD MILLION) 286 TABLE 122 INDONESIA TOPICAL CORTICOSTEROIDS MARKET, BY POTENCY CLASS, 2015 – 2024 (USD MILLION) 287 TABLE 123 INDONESIA TOPICAL CORTICOSTEROIDS MARKET, BY END-USER, 2015 – 2024 (USD MILLION) 287 TABLE 124 INDONESIA TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) 288 TABLE 125 PHILIPPINES TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015 – 2024 (USD MILLION) 289 TABLE 126 PHILIPPINES TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE , 2015 – 2024 (USD MILLION) 289 TABLE 127 PHILIPPINES TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION) 290 TABLE 128 PHILIPPINES TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE, 2015 – 2024 (USD MILLION) 290 TABLE 129 PHILIPPINES TOPICAL CORTICOSTEROIDS MARKET, BY POTENCY CLASS, 2015 – 2024 (USD MILLION) 292 TABLE 130 PHILIPPINES TOPICAL CORTICOSTEROIDS MARKET, BY END-USER, 2015 – 2024 (USD MILLION) 292 TABLE 131 PHILIPPINES TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) 293 TABLE 132 INDONESIA TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015 – 2024 (USD MILLION) 294 FIGURES LIST FIGURE 1 ASIA PACIFIC TOPICAL CORTICOSTEROIDS MARKET: SEGMENTATION 38 FIGURE 2 ASIA PACIFIC TOPICAL CORTICOSTEROIDS MARKET: DATA TRIANGULATION 42 FIGURE 3 ASIA PACIFIC TOPICAL CORTICOSTEROIDS MARKET: RESEARCH SNAPSHOT 43 FIGURE 4 ASIA PACIFIC TOPICAL CORTICOSTEROIDS MARKET : BOTTOM UP APPROACH 45 FIGURE 5 ASIA PACIFIC TOPICAL CORTICOSTEROIDS MARKET : TOP DOWN APPROACH 45 FIGURE 6 ASIA PACIFIC TOPICAL CORTICOSTEROIDS MARKET: INTERVIEW DEMOGRAPHICS 46 FIGURE 7 ASIA PACIFIC IS THE HIGHEST GROWING AND MOST PROFITABLE REVENUE POCKETS FOR TOPICAL CORTICOSTEROIDS MANUFACTURERS IN THE FORECAST PERIOD 2017 TO 2024 58 FIGURE 8 ASIA PACIFIC TOPICAL CORTICOSTEROIDS MARKET: BY MOLECULE NAME, SNAPSHOT 2016 60 FIGURE 9 ASIA PACIFIC TOPICAL CORTICOSTEROIDS MARKET: BY POTENCY CLASS, 2016 73 FIGURE 10 ASIA PACIFIC TOPICAL CORTICOSTEROIDS MARKET: BY APPLICATION, 2016 86 FIGURE 11 ASIA PACIFIC TOPICAL CORTICOSTEROIDS MARKET: BY MEDICATION TYPE, 2016 96 FIGURE 12 ASIA PACIFIC TOPICAL CORTICOSTEROIDS MARKET: BY END-USER, 2016 108 FIGURE 13 ASIA PACIFIC TOPICAL CORTICOSTEROIDS MARKET: BY DISTRIBUTION CHANNEL, 2016 115 FIGURE 14 ASIA PACIFIC TOPICAL CORTICOSTEROIDS MARKET: BY PURCHASE MODE, 2016 122 FIGURE 15 ASIA PACIFIC TOPICAL CORTICOSTEROIDS MARKET SNAPSHOT (2016) 132 FIGURE 16 ASIA PACIFIC TOPICAL CORTICOSTEROIDS MARKET: BY GEOGRAPHY (2016) 133 FIGURE 17 ASIA PACIFIC TOPICAL CORTICOSTEROIDS MARKET: BY GROGRAPHY (2017 & 2024) 134 FIGURE 18 ASIA PACIFIC TOPICAL CORTICOSTEROIDS MARKET: BY GEOGRAPHY (2016 & 2024) 135 FIGURE 19 ASIA PACIFIC TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME (2017 & 2024) 136 FIGURE 20 ASIA-PACIFIC TOPICAL CORTICOSTEROIDS MARKET SNAPSHOT (2016) 231 FIGURE 21 ASIA-PACIFIC TOPICAL CORTICOSTEROIDS MARKET: BY COUNTRY (2016) 232 FIGURE 22 ASIA-PACIFIC TOPICAL CORTICOSTEROIDS MARKET: BY COUNTRY (2017 & 2024) 233 FIGURE 23 ASIA-PACIFIC TOPICAL CORTICOSTEROIDS MARKET BY COUNTRY (2016 & 2024) 234 FIGURE 24 ASIA-PACIFIC TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME (2017 & 2024) 235 FIGURE 25 ASIA PACIFIC TOPICAL CORTICOSTEROIDS MARKET: COMPANY SHARE 2016 (%) 331 FIGURE 26 ASIA PACOFIC TOPICAL CORTICOSTEROIDS MARKET: COMPANY SHARE 2016 (%) 334

• LEO Pharma • Glaxosmithkline Plc, • Pfizer Inc.